Biologic May Tame Severe Asthma – MedPage Today


The Pharma Letter

Biologic May Tame Severe Asthma
MedPage Today
A. A. Take Posttest. SAN DIEGO — Lebrikizumab, a novel monoclonal antibody against the inflammatory cytokine IL-13, might have reduced exacerbations in severe asthma in a randomized trial, although manufacturing problems undermined any conclusions.
Roche drug cuts asthma attacks, improves lung function -studyReuters
Roche scores upbeat data for a personalized asthma drug with blockbuster hopesFierceBiotech
AAAAI 2014: Roche's lebrikizumab shows reduction of asthma attack ratesThe Pharma Letter
Drug Discovery & Development –PharmaTimes
all 11 news articles »

View full post on asthma – Google News

Plant Compounds Ease Asthma, Allergies – MedPage Today

Plant Compounds Ease Asthma, Allergies
MedPage Today
SAN DIEGO — Anti-inflammatory plant estrogen compounds found in soy and flaxseed were associated with less asthma and allergic disease, a national observational study showed. People with the highest urinary levels of phytoestrogens from flax and soy 
Flax Seeds, Soy Beans May Help Asthma and AllergyMedscape

all 2 news articles »

View full post on asthma – Google News

Blame LABA Risks in Asthma on Gene Variants? – MedPage Today


Science World Report

Blame LABA Risks in Asthma on Gene Variants?
MedPage Today
Six variants in the beta2-adrenergic receptor gene (ADRB2) found in fewer than 5% of LABA-treated asthma patients were associated with double the incidence of a related hospital admission overall compared with common variants (44% versus 22% in 12 
LABA Drugs for Asthma May Negatively Impact People With Rare Genetic Science World Report
Rare Genetic Variations May Account For Severe Reaction To LABA Drugs In RedOrbit

all 12 news articles »

View full post on asthma – Google News